Particularly, p52 appears to be necessary for sustaining and potentially initiating the activity of MM specific regulatory elements that potentiate pro-oncogenic super-enhancer and target driver gene cis-regulatory pairings like BCL2 and RGS1. Here, RGS1 is linked to Miyoshi myopathy.